ストックスクリーナーアプリを入手
0.27
24.51%
-0.0413
アフターアワーズ：
.27
前日終値:
$0.3113
開ける：
$0.28
24時間の取引高:
111.66K
Relative Volume:
66.00
時価総額：
$N/A
収益：
-
当期純損益:
$-21.33M
株価収益率:
-0.00237
EPS:
-113.7479
ネットキャッシュフロー:
$-9.12M
1週間 パフォーマンス:
-24.51%
1か月 パフォーマンス:
-62.29%
6か月 パフォーマンス:
-84.44%
1年 パフォーマンス:
-93.80%
1日の値動き範囲:
$0.24
$0.2833
1週間の範囲:
$0.24
$0.2833
52週間の値動き範囲:
$0.24
$0.2833
Zyversa Therapeutics Inc Stock (ZVSA) Company Profile
ZVSA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ZVSA
Zyversa Therapeutics Inc
|
0.27 | 0 | 0 | -21.33M | -9.12M | -113.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Zyversa Therapeutics Inc (ZVSA) 最新ニュース
When is ZyVersa Therapeutics Inc. stock expected to show significant growthMarket-leading growth rates - jammulinksnews.com
What makes ZyVersa Therapeutics Inc. stock price move sharplyDiscover stocks with strong growth potential - jammulinksnews.com
Is it the right time to buy ZyVersa Therapeutics Inc. stockHigh-impact investment strategies - jammulinksnews.com
What institutional investors are buying ZyVersa Therapeutics Inc. stockDouble or triple returns - jammulinksnews.com
Published on: 2025-07-27 20:08:17 - jammulinksnews.com
Is ZyVersa Therapeutics Inc. a growth stock or a value stockUnlock exclusive trading tools and resources - jammulinksnews.com
Key External Factors That Drive ZyVersa Therapeutics Inc. Stock Price MovementsRisk Managed Trading Strategy - Newser
Is ZyVersa Therapeutics Inc. a Top Dividend Stock to Watch in 2025Big Return Stock Tips - Newser
ZyVersa Therapeutics Inc. Stock Analysis and ForecastConsistently high returns - PrintWeekIndia
What analysts say about ZyVersa Therapeutics Inc. stockExceptional profit potential - Autocar Professional
Is ZyVersa Therapeutics Inc. a good long term investmentRapid-fire capital growth - Autocar Professional
What drives ZyVersa Therapeutics Inc. stock priceRapidly growing investment returns - jammulinksnews.com
ZyVersa Therapeutics CEO Issues Mid-year Shareholder Letter - GlobeNewswire
ZyVersa secures $12 million in financing to advance kidney disease trials - Investing.com Canada
ZyVersa Therapeutics Updates Shareholders on Key Developments and R&D Milestones in Mid-Year Letter - Nasdaq
ZyVersa Therapeutics Raises $12M to Accelerate Breakthrough Kidney and Inflammatory Disease Treatments - Stock Titan
ZVSA’s Market Whiplash: -93.65% YTD Decline, -52.27% Plunge in 30 Days - investchronicle.com
Why ZyVersa Therapeutics Inc. stock attracts strong analyst attentionFree Best Performing Stock Suggestions - Newser
ZyVersa Therapeutics to be delisted from Nasdaq, trading to move to OTC market - Investing.com India
ZyVersa Therapeutics Faces Nasdaq Delisting, Plans Pink Market Move - TipRanks
ZyVersa Therapeutics to be delisted from Nasdaq, trading to move to OTC market By Investing.com - Investing.com South Africa
How ZyVersa Therapeutics Inc. stock performs during market volatilityWatchlist Winner Update - Newser
ZyVersa Therapeutics (NASDAQ:ZVSA) Rating Increased to Hold at Wall Street Zen - Defense World
ZyVersa Therapeutics (ZVSA) Stock Price, News & Analysis - MarketBeat
ZyVersa Therapeutics Supports FDA-Authorized Emergency Compassionate Use of Cholesterol Efflux Mediator?? VAR 200 in A Patient with ApoCII Amyloidosis - MarketScreener
Why Did ZyVersa Therapeutics Plunge 10% Despite Funding Boost? - AInvest
ZyVersa Therapeutics (NASDAQ:ZVSA) Shares Up 17.4% – Time to Buy? - Defense World
ZyVersa Therapeutics Enters Warrant Exercise Agreement - TipRanks
ZyVersa Therapeutics Supports FDA-Authorized Emergency - GlobeNewswire
ZyVersa Secures $2 Mln Through Warrant Inducement Deal With Institutional Investor - Nasdaq
ZVSA’s Stock Journey: What Investors Need to Know About ZyVersa Therapeutics Inc’s Performance - investchronicle.com
Why Did ZyVersa Therapeutics Stock Shoot Higher On Tuesday? - Benzinga
Intensity Therapeutics Inc’s Shares Reel: -85.34% Quarterly Revenue Decline Amid 7.38M Market Cap - investchronicle.com
ZyVersa announces warrant inducement transaction for $2M in gross proceeds - TipRanks
ZyVersa Therapeutics Announces a Warrant Inducement Transaction for $2.0 Million in Gross Proceeds - GlobeNewswire
Zyversa Therapeutics Inc (ZVSA) 財務データ
収益
当期純利益
現金流量
EPS
0.97%
0.22%
大文字化:
|
ボリューム (24 時間):